U.S. senators called drug pricing practices 'morally repugnant' and to...
WASHINGTON/NEW YORK - U.S. senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at a Senate hearing on the rising costs of prescription medicines.
Executives from AstraZeneca PLC, Sanofi SA, Pfizer Inc, Merck & Co, Johnson & Johnson and Bristol-Myers Squibb Co also answered questions from members of the U.S. Senate Finance Committee. The executives also voiced support for plans to reform the industry-wide system of rebates that pharmacy benefit managers and health insurers receive from drugmakers in exchange for preferential coverage of their medicines.
The drug has a list price of more than $60,000 a year, nearly double what it was in 2014, according to Rx Savings Solutions, which helps health plans and employers seek lower cost prescription medicines. Congress has already held several hearings on rising prescription drug prices in both the Democrat-controlled House of Representatives and the Republican-led Senate, but Tuesday’s hearing is the first time drug company executives, most of them CEOs, will face lawmakers in more than two years.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Expect a rate hike in June, economist says'What is the moral of monetary policy here? What is driving monetary policy? And in the end, it's either the whims of the stock market or it's political pressure — or at least that's what it seems,' this expert said on the Fed's policy decisions.
Leer más »
Jussie Smollett, Believing the Victim, and Deep National Wounds | OpinionStatistically, the sympathy for Smollett makes sense. But 'Believe the victim. Period' is not the type of moral reasoning that will move our communities and nation to peaceful and just coexistence.
Leer más »